TEMENOS
8.4.2021 14:02:13 CEST | Business Wire | Press release
Temenos (SIX: TEMN), the banking software company, today announced that Salmon Arm Savings and Credit Union (SASCU) has extended its long-standing relationship with Temenos, completing an implementation of the newest functionality of Temenos Analytics to drive its growth strategy. With 20,000 members, and $800 million assets under management, SASCU continues to grow in size and product offerings, using Temenos Analytics to deliver seamless, hyper-personalized digital experiences for its members.
According to a recent report by the Economist Intelligence Unit , improving the account holder experience and engagement is the top strategic priority for financial institutions around the world. SASCU is a forward-looking, community-focused, financial organization driven to provide world-class products and services for all phases of a member’s life. Recognizing the power of data, SASCU has been using Temenos Analytics to drive profitability and strategy for 10+ years as it has grown. Focused on attracting and retaining members, and expanding wallet share through an outstanding experience, SASCU is one of the top performing credit unions in Canada.
Temenos Services Partner ClearSight Solutions collaborated with Temenos to implement additional capabilities at the credit union to modernize the way SASCU uses data with Temenos’ industry-leading funds transfer pricing and activity-based costing capabilities. Leveraging the full strength of Temenos’ powerful reporting tools, SASCU can now calculate the profitability of every member and product using industry best practice financial models in order to identify areas for improvement and new product development. This will enable the credit union to improve financial performance and the member experience.
Over the past five years, online banking visits have nearly doubled. A seamless digital member experience is vital to SASCU’s member acquisition and retention goals. Temenos Analytics is core-agnostic, allowing SASCU to run on a third-party core, break down data silos and improve data accuracy, all with a single view.
Barry Delaney, President and Chief Financial Officer, SASCU Financial Group, commented: “Our vision is to be our members’ lifelong partner – to do that, we need to make sure that we are offering them the products and services they need. Advice and member experience is not one-size-fits-all. We continuously seek new ways of doing things, and for that we need to fully leverage our data. Temenos has enabled us to enhance the range of products we offer in order to deliver better choice, value, and a member-centric experience. By expanding our relationship with Temenos and implementing the enhanced functionality, we will empower our employees to better serve our members, and fully leverage data to drive our strategy.”
Jacqueline White, President, Americas, Temenos, said: “Financial institutions face many challenges such as the acceleration of digital, intense competition, changing account holder behavior, and high operating costs. Continued investment in innovation and technology is vital to success, which is why more than 30 Canadian banks and credit unions partner with Temenos. As a leading provider of banking technology, Temenos enables SASCU to overcome these challenges and create hyper-personalized experiences, ensure higher member satisfaction and increase profits. We’re delighted that, supported by ClearSight’s valuable in-depth business and technical knowledge, SASCU has implemented additional Temenos technology, and we look forward to continuing to support the team as it continues to grow and create meaningful member relationships.”
Michael Zywicki, Partner, ClearSight Solutions, added: “By deploying Temenos Analytics, SASCU demonstrates its understanding that modern tools and data are required to better understand members’ activities and relationship value. ClearSight is excited to be part of this project and to see how SASCU uses the enhanced knowledge of their members to provide them with a differentiated experience.”
– Ends –
About SASCU
SASCU Financial Group offers a broad range of personal and business financial services through SASCU Credit Union and its three lines of business, SASCU Insurance, SASCU Wealth and Commercial banking. SASCU Credit Union branches are in Sicamous and Sorrento, plus two in Salmon Arm. Insurance offices are located in Salmon Arm and Enderby. Established in 1946, SASCU has more than 19,000 members, 150 staff and $900 million in assets. In addition, SASCU stewards $235 million in client investments and serves more than 5000 insurance customers. Learn more at sascu.com .
About Temenos
Temenos AG (SIX: TEMN) is the world’s leader in banking software. Over 3,000 banks across the globe, including 41 of the top 50 banks, rely on Temenos to process both the daily transactions and client interactions of more than 1.2 billion banking customers. Temenos offers cloud-native, cloud-agnostic and AI-driven front office, core banking, payments and fund administration software enabling banks to deliver frictionless, omnichannel customer experiences and gain operational excellence.
Temenos software is proven to enable its top-performing clients to achieve cost-income ratios of 26.8% half the industry average and returns on equity of 29%, three times the industry average. These clients also invest 51% of their IT budget on growth and innovation versus maintenance, which is double the industry average, proving the banks’ IT investment is adding tangible value to their business. For more information, please visit www.temenos.com .
About ClearSight
ClearSight Solutions is a Canadian headquartered company with offices in Vancouver, Canada, London, UK and San Jose, Costa Rica whose sole purpose is giving customers the best experience and service they deserve.
As a Temenos Partner, ClearSight provides expert services to deliver on premise or cloud-based data and analytics products. Our mission is to work with customers throughout their data and analytics journey to drive maximum value from their data and analytic investments.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210408005047/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
New Auction Record Set as Falcon Sells for AED 1.5 Million at ADIHEX 202629.8.2026 23:54:00 CEST | Press release
Qarmousha Pure Ultra White falcon sells for AED 1.5 million at the Abu Dhabi International Hunting and Equestrian Exhibition 2026 (ADIHEX) falcon auction Under the patronage of His Highness Sheikh Hamdan bin Zayed Al Nahyan, Ruler’s Representative in Al Dhafra Region and Chairman of the Emirates Falconers’ Club, the fifth auction held as part of the 23rd edition of the Abu Dhabi International Hunting and Equestrian Exhibition (ADIHEX) 2026 attracted remarkable turnout, culminating in the sale of a Qarmousha Pure Ultra White falcon for AED 1.5 million (USD 408,000). The sale marks the highest price achieved at any auction during this year’s edition of the exhibition. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260829032621/en/ Qarmousha Pure Ultra White (Photo: AETOSWire) This forms part of the largest auction programme in the exhibition’s history, held under the theme “A Legacy of Pride,” organised by ADNEC Group, a Modon
Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera29.8.2026 00:40:00 CEST | Press release
MIMRYLO, a First-in-Class Medicine with a Unique Mechanism of Action, is Approved for the Treatment of Erythrocytosis in Adults with Polycythemia Vera (PV)MIMRYLO Has Been Shown to Maintain Hematocrit Control, the Primary Treatment Goal in PV, as Well as Reduce Phlebotomy Burden and Improve FatigueApproval Supported by Phase 3 VERIFY Results Showing 76.9% of Patients Achieved Clinical Response During Weeks 20-32 Takeda (TSE:4502/NYSE:TAK)announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for MIMRYLO™ (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260824773270/en/ MIMRYLO Logo MIMRYLO is a first-in-class hepcidin mimetic designed to regulate iron distribution in the body and red blood cell overproduction to control hematocrit levels, which is the ratio of red blood cells to the tot
Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 16:00:00 CEST | Press release
Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me
BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 15:34:00 CEST | Press release
Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro
Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 11:00:00 CEST | Press release
Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026 The approval is based on data from the Phase 3 RISE-PD trial where Hopledo® demonstrated a significant increase in Good ON time compared with immediate-release LD/CD with fewer daily doses and a comparable safety profile Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
